Browsing Tag
Ltd.
43 posts
Is Honda Motor building a data-center-grade AI brain for cars? Inside its 100x energy-efficient analog chip bet
Find out how Honda’s partnership with Mythic could redefine in-vehicle AI with 100x energy efficiency and reshape autonomous driving economics.
Coway Co., Ltd. outlines early execution gains from its Corporate Value-Up Plan as dividends and governance become strategic levers
Coway Co., Ltd. reports early gains from its Corporate Value-Up Plan. Find out why dividends, governance, and execution discipline now matter more.
Samsung is quietly testing One UI 8.5 for mid-range phones—here’s why that matters
Samsung starts testing One UI 8.5 on Galaxy M55s, signaling a broader Android 16 rollout strategy. Find out how this could reshape Samsung’s update roadmap.
Why did Amgen Inc. walk away from its $1.25bn eczema drug deal with Kyowa Kirin?
Amgen Inc. exits its $1.25B eczema drug deal with Kyowa Kirin Co., Ltd., reshaping its immunology focus. Find out what this move means for both companies’ pipelines.
Residential solar adoption in Singapore accelerates as Springview Holdings partners with Jiangsu GSO New Energy
Find out how Springview Holdings is partnering with Jiangsu GSO New Energy to accelerate residential solar and green energy adoption in Singapore.
SHACMAN launches next-gen H3000S in Saudi Arabia, signaling new phase in Middle East heavy-duty trucking competition
SHACMAN has launched its next-generation H3000S truck in Saudi Arabia. Find out how fuel efficiency and service strategy could reshape fleet economics.
PRISM BioLab and Talus Bioscience aim to crack the transcription factor code with dual-platform drug discovery strategy
PRISM BioLab and Talus Bio have teamed up to crack transcription factor drug discovery. Find out how their dual-platform strategy could reshape precision medicine.
TOYO Co., Ltd. buys out remaining stake in TOYO Solar LLC to strengthen U.S. clean energy footprint
Find out how TOYO Co., Ltd.’s full takeover of TOYO Solar LLC strengthens its U.S. manufacturing strategy and reshapes its clean-energy growth outlook.
Can Ping An Biomedical regain compliance before May 2026? What investors should know
Ping An Biomedical faces Nasdaq delisting risk after falling below $1 per share. Find out what this means for investors and what could happen next.
Kehua Bio-engineering debuts Polaris V150 as the new compact workhorse for clinical labs
Discover how Kehua Bio-engineering’s Polaris V150 analyzer is transforming compact lab diagnostics with automation and accuracy.